A Dose Escalation Study to Evaluate the Safety and Tolerability of IBI302 Intravitreal Injection in Subjects With Neovascular Age-related Macular Degeneration and Diabetic Macular Edema AND A Multi-center, Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of IBI302 in Subjects With Diabetic Macular Edema
Latest Information Update: 31 Jul 2023
At a glance
- Drugs Efdamrofusp alfa (Primary) ; Aflibercept
- Indications Diabetic macular oedema; Wet age-related macular degeneration
- Focus Adverse reactions
- Sponsors Innovent Biologics
- 31 Jul 2023 New trial record